Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6
Primary Industries
- Medical
- Device
- Surgical
- Specialty
- Storage
- Stem cells
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 1466
License Grant
Purchaser shall retain exclusive ownership rights in, and exclusive rights to exploit, U.S. Patent No. 5,190,556 included in the Assets (the “Patentâ€) and any other patents included in the Assets or otherwise arising out of the Assets (the “Additional Patentsâ€), and have no obligation to grant the Company any rights therein.
License Property
CordguardTM – disposable umbilical blood sampling system. Designed to minimize clinian exposure to cord blood while cutting the umbilical cord and collecting vital newborn blood samples.
IPSCIO Record ID: 4928
License Grant
The Company and the NYBC, as co-licensors, entered into a license agreement in which the Licensees became the exclusive worldwide manufacturers and distributors (excluding Japan) for the system of sterile, medical disposable containers developed by the Company and NYBC for the processing of hematopoietic stem cells sourced from PCB. Licensor grants to Licensee, under the terms and conditions of this Agreement, an exclusive license within the Exclusive Field of Use and the Non-Exclusive Field of Use under the Licensed Patent Rights and Know-How (a) to make, use, sell, or otherwise dispose of the Licensed Products, and (b) to use the methods covered by the Licensed Patent Rights and Know-How for the manufacture, use and sale of Licensed Products. Licensor retains for itself the right to practice for itself, without the right to sublicense distribution, the Licensed Patent Rights and Know How within the Non-Exclusive Field of Use and to use the methods covered by the Licensed Patent Rights and Know-How.
License Property
Licensor has developed know-how and patent rights for plastic disposable bags or containers for the isolation, collection, processing, freezing and infusion of stem cells for use with placental/umbilical cord blood.
Method of Isolation of Stem Cells and Bag Array U.S. #08/349,747
Improved Bag Design and Method of Manufacturing U.S. #08/670,368
Field of Use
Exclusive Field of Use@ shall mean the practice of stem cell isolation and collection from umbilical cord blood, and the freezing, storage, processing and infusion of such stem cells.
Non-Exclusive Field of Use@ shall mean all other applications of the Licensed Product.
Non-Exclusive Field of Use@ shall mean all other applications of the Licensed Product.
IPSCIO Record ID: 3056
License Grant
The Licensor entered into a License Agreement with the Licensee to establish and market the Licensor's U-Cord business in Germany with the option to expand the Licensed territory to include Italy, Spain and France.
License Property
The Licensor is engaged in cellular processing and cryogenic storage, with a current focus on the collection and preservation of umbilical cord (U-Cord®) blood stem cells for family use.
Field of Use
The Licensee has been providing families an opportunity to cryogenically preserve their newborn's umbilical cord blood stem cells in a safe and secure environment. This service is called U-Cord.
IPSCIO Record ID: 133630
License Grant
The Company purchased certain assets associated with the manufacture and sale of the arterial blood gas products (the 'ABG Assets') and the Company then leased the ABG Assets back to Licensee in exchange for a royalty of the net arterial blood gas product line sales.
License Property
ABG Assets are the arterial blood gas products which are used for specialty cardiopulmonary support, respiratory and anesthesia disposable devices.
Field of Use
This agreement pertains to the medical industry.
IPSCIO Record ID: 246210
License Grant
The Licensor grants the Licensee an exclusive licence to use, process, test and store the Materials (umbilical cord tissue samples) and Mesenchymal Stem Cells; produce Licensed Product, including the creation of Derivatives and Progeny from Materials; supply Licensed Product to third parties and to provide services in relation to such Licensed Product to third parties; and sub-licence its rights to Affiliates and to third party service providers.
License Property
The procurement of Mesenchymal Stem Cells derived from umbilical cord blood or placenta to be used for research purposes. Materials are only for use in humans or for human application.
Field of Use
Cord Blood/Tissue, derived cells, progeny or derivative may be supplied and used in research projects if conducted in accordance with certain conditions.
License is for the methodology for producing clinical-grade pooled human umbilical cord derived mesenchymal stem/stromal cells (“HucMSCâ€) at industrial scale.
IPSCIO Record ID: 27347
License Grant
The Company entered into an agreement with an undisclosed Licensor for card-vascular products.
License Property
Bio-Vascular Probe is a flexible shaft with varying sizes of bulbous tips on either end. Biograft is used to bypass occluded blood vessels and is produced from modified human umbilical veins.
Field of Use
Surgeons use the Bio-Vascular Probe to locate occlusions or blockages in arteries and to ascertain the blood flow characteristics of arteries.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
